Literature DB >> 23045597

Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome?

David Raben, Paul A Bunn.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23045597     DOI： 10.1200/JCO.2012.43.1866

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Authors:  Joshua D Palmer; Nicholas G Zaorsky; Matthew Witek; Bo Lu
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG).

Authors:  Rogerio Lilenbaum; Michael Samuels; Xiaofei Wang; Feng Ming Kong; Pasi A Jänne; Gregory Masters; Sreedhar Katragadda; Lydia Hodgson; Jeffrey Bogart; Jeffrey Bradley; Everett Vokes
Journal:  J Thorac Oncol       Date:  2015-01       Impact factor: 15.609

Review 3.  State of the art of radiotherapy.

Authors:  Pilar Garrido; Eugenia Olmedo
Journal:  Transl Lung Cancer Res       Date:  2013-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.